DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role
DaVita (NYSE: DVA), a leading kidney care provider, has announced key leadership changes effective September 15, 2024. David Maughan, an 18-year DaVita veteran, will become the new chief operating officer, succeeding Mike Staffieri, who transitions to chief operating officer emeritus after 11 years in the role.
Maughan brings extensive experience, having held various leadership positions at DaVita, including overseeing strategic functions for hospital and home treatment businesses. His leadership has impacted over 65,000 employees and 200,000 patients. Staffieri, with a 25-year tenure at DaVita, will continue working on key strategic initiatives to drive clinical differentiation in kidney care.
As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers globally, with 2,672 centers in the United States and 452 in 13 other countries.
DaVita (NYSE: DVA), un leader nella cura dei reni, ha annunciato importanti cambiamenti nella leadership che entreranno in vigore il 15 settembre 2024. David Maughan, un veterano di DaVita con 18 anni di esperienza, diventerà il nuovo direttore operativo, subentrando a Mike Staffieri, che passerà a ricoprire il ruolo di direttore operativo emerito dopo 11 anni nel suo incarico.
Maughan porta con sé una vasta esperienza, avendo ricoperto diverse posizioni dirigenziali in DaVita, incluso il monitoraggio delle funzioni strategiche per le attività ospedaliere e di trattamento domiciliare. La sua leadership ha avuto un impatto su oltre 65.000 dipendenti e 200.000 pazienti. Staffieri, che è in DaVita da 25 anni, continuerà a lavorare su importanti iniziative strategiche per promuovere la differenziazione clinica nella cura dei reni.
Al 30 giugno 2024, DaVita assisteva circa 265.100 pazienti in 3.124 centri di dialisi ambulatoriali a livello globale, con 2.672 centri negli Stati Uniti e 452 in 13 altri paesi.
DaVita (NYSE: DVA), un proveedor líder en el cuidado renal, ha anunciado cambios clave en el liderazgo que entrarán en vigor el 15 de septiembre de 2024. David Maughan, un veterano de 18 años en DaVita, se convertirá en el nuevo director operativo, sucediendo a Mike Staffieri, quien pasará a ser director operativo emérito después de 11 años en el cargo.
Maughan aporta una amplia experiencia, habiendo ocupado diversas posiciones de liderazgo en DaVita, incluyendo la supervisión de funciones estratégicas para negocios de tratamiento hospitalario y domiciliario. Su liderazgo ha impactado a más de 65,000 empleados y 200,000 pacientes. Staffieri, con 25 años de trayectoria en DaVita, continuará trabajando en iniciativas estratégicas clave para impulsar la diferenciación clínica en el cuidado renal.
A partir del 30 de junio de 2024, DaVita atendió aproximadamente a 265,100 pacientes en 3,124 centros de diálisis ambulatoria en todo el mundo, con 2,672 centros en Estados Unidos y 452 en 13 otros países.
DaVita (NYSE: DVA), 신장 치료의 선도 기업인 다비타가 2024년 9월 15일부터 적용되는 주요 리더십 변화를 발표했습니다. David Maughan, 18년 경력의 다비타 베테랑이 최고 운영 책임자로 취임하게 되며, Mike Staffieri는 11년 동안의 역할을 마치고 최고 운영 책임자 명예직으로 전환합니다.
Maughan은 다비타에서 다양한 리더십 역할을 수행하며 병원 및 홈 치료 사업의 전략적 기능을 감독한 방대한 경험을 가지고 있습니다. 그의 리더십은 65,000명 이상의 직원과 200,000명의 환자에게 영향을 미쳤습니다. 25년 경력의 Staffieri는 다비타에서 지속적으로 신장 치료의 임상 차별화를 추진하기 위한 주요 전략적 이니셔티브에 집중할 것입니다.
2024년 6월 30일 기준, 다비타는 전 세계적으로 3,124개의 외래 투석 센터에서 약 265,100명의 환자를 치료하였으며, 이중 2,672개는 미국에 있고 452개는 13개 다른 국가에 있습니다.
DaVita (NYSE: DVA), un fournisseur de soins rénaux de premier plan, a annoncé des changements clés dans sa direction qui entreront en vigueur le 15 septembre 2024. David Maughan, un vétéran de DaVita avec 18 ans d'expérience, assumera le poste de nouveau directeur des opérations, succédant à Mike Staffieri, qui passera au poste de directeur des opérations émérite après 11 ans dans cette fonction.
Maughan apporte une vaste expérience, ayant occupé divers postes de direction chez DaVita, y compris la supervision des fonctions stratégiques pour les traitements hospitaliers et à domicile. Son leadership a eu un impact sur plus de 65 000 employés et 200 000 patients. Staffieri, qui a une carrière de 25 ans chez DaVita, continuera à travailler sur des initiatives stratégiques clés pour promouvoir la différenciation clinique dans le soin des reins.
Au 30 juin 2024, DaVita servait environ 265 100 patients dans 3 124 centres de dialyse ambulatoire à l'échelle mondiale, avec 2 672 centres aux États-Unis et 452 dans 13 autres pays.
DaVita (NYSE: DVA), ein führender Anbieter von Nierenpflege, hat wesentliche Änderungen in der Unternehmensführung angekündigt, die am 15. September 2024 in Kraft treten werden. David Maughan, ein langjähriger Mitarbeiter von DaVita mit 18 Jahren Erfahrung, wird neuer Chief Operating Officer und tritt die Nachfolge von Mike Staffieri an, der nach 11 Jahren in dieser Rolle zum emeritierten Chief Operating Officer wechselt.
Maughan bringt umfassende Erfahrungen mit, da er verschiedene Führungspositionen bei DaVita innehatte, darunter die Überwachung strategischer Funktionen für Krankenhaus- und Häuslichebehandlungsbusiness. Seine Führung hat über 65.000 Mitarbeiter und 200.000 Patienten beeinflusst. Staffieri, der seit 25 Jahren bei DaVita tätig ist, wird weiterhin an wichtigen strategischen Initiativen arbeiten, um klinische Unterschiede in der Nierenpflege voranzutreiben.
Zum 30. Juni 2024 betreute DaVita weltweit etwa 265.100 Patienten in 3.124 ambulanten Dialysezentren, davon 2.672 in den Vereinigten Staaten und 452 in 13 weiteren Ländern.
- David Maughan's appointment as COO brings 18 years of company experience to the role
- Mike Staffieri will continue to contribute as COO emeritus, focusing on strategic initiatives
- DaVita serves a large patient base of 265,100 across 3,124 global outpatient dialysis centers
- None.
"It's an exciting time for DaVita! Dave's extensive experience in operations leadership coupled with his deep knowledge of DaVita's business positions him well to build upon our incredible foundation of operational excellence and lead our ongoing efforts in care delivery and healthcare innovation," said Javier Rodriguez, CEO of DaVita. "I'm grateful for Mike's steadfast leadership and continued commitment to serve as COO emeritus, working on high-impact strategic initiatives."
Since joining DaVita in 2006, Maughan has held several leadership positions with growing responsibilities, including more than a decade in operations leadership roles. Most recently, Maughan was a senior vice president at DaVita, overseeing strategic functions dedicated to DaVita's hospital and home treatment businesses. His leadership also extended to functions like human resources, talent strategy, IT, state government affairs, marketing, and communications. His work affected over 65,000 employees and 200,000 patients.
"I'm honored to step into the role of chief operating officer at DaVita, supporting our talented operations teams as they deliver an integrated kidney care platform that is designed to seamlessly support patients through every phase of care," Maughan said. "At DaVita, we believe deeply that the differentiated environment we foster for teammates results in a better care environment for patients. We're well-positioned to make a significant impact on the lives of those with kidney disease and beyond."
In his new role, Staffieri builds on his 25-year tenure at DaVita. He will continue to work closely with DaVita's executive leadership team on key strategic initiatives to drive advanced clinical differentiation in kidney care.
For more information about the executive leadership team, visit DaVita.com/About.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Media Contact:
DaVita Newsroom
newsroom@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-appoints-david-maughan-new-chief-operating-officer-mike-staffieri-steps-into-emeritus-role-302247370.html
SOURCE DaVita
FAQ
Who is the new Chief Operating Officer of DaVita (DVA)?
What is Mike Staffieri's new role at DaVita (DVA)?
How many patients does DaVita (DVA) serve as of June 30, 2024?
How long has David Maughan been with DaVita (DVA)?
